Perbedaan Indopoly Swakarsa Industry Tbk dan Brigit Biofarmaka Teknologi Tbk.: Indopoly Swakarsa Industry Tbk diperdagangkan di Rp106 (kapitalisasi pasar 689,44 M, volume 24 jam 236,1 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Indopoly Swakarsa Industry Tbk jauh lebih besar — sekitar 4,1× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Indopoly Swakarsa Industry Tbk lebih aktif diperdagangkan (236,1 rb vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IPOL | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 689,44 M | 167,37 M |
Volume | 236,1 rb | 96,7 rb |
Lot | 2,36 rb | 967 |
Perputaran | 25,04 jt | 23,82 jt |
Harga Rata-rata | 106,05 | 246,34 |
Nilai Transaksi | 25,04 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | 106 | 248 |
Volume Ekuilibrium Indikatif | 18 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Selengkapnya di halaman IPOL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →